![CAS 260-50-4 Benzo[g]quinoxaline molecular structure](https://starshinechemical.com/wp-content/uploads/2022/03/b4540-jpgcontextbwfzdgvyfhjvb3r8mzuxmjd8aw1hz2uvanblz3xomwivagjklzg5mjkwntcxmtiwotqvqjq1ndauanbnfgm4ngmzzdg4mtdmm2e2mwe2y2vjndbhmdu5zdnintyxmdu5mzyxzduyn2m1yje1mjbknzyzzmzmm2nlmtnknjc.jpeg)
CAS RN: 260-50-4
Benzo[g]quinoxaline
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
|---|---|---|---|---|
| Batchno.20250607 | 200mg / 1g | Confirm by inquiry | Shanghai | Inquiry |
- Product code: SSC-122811
Historical Factory Record
Historical Supply Reference
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
- Pack sizes on record: 1g
- Available purity: ≥98%
- Inventory rows with stock: 0
- Bulk packaging: confirmed by inquiry
Reference Pack Sizes
Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.
| Pack Size | Recorded Purity | Available Qty | Ship From | Inquiry |
|---|---|---|---|---|
| 1g | ≥98% | 0 Out of Stock | Hong Kong | Inquiry |
260-50-4 / benzo[g]quinoxaline
Basic Information
CAS
260-50-4
Multi CAS
No
Molecular Formula
C12H8N2
Molecular Weight
180.200000
Exact Mass
180.068748
SMILES
C1=CC=C2C=C3C(=CC2=C1)N=CC=N3
InChI
InChI=1S/C12H8N2/c1-2-4-10-8-12-11(7-9(10)3-1)13-5-6-14-12/h1-8H
InChIKey
XEMRLVBSKVCUDL-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
14
Aromatic heavy atom count
14
H-bond acceptors
2
Molar refractivity
57.04
TPSA
25.78
LogP / Solubility
WLOGP
2.78
MLOGP
2.45
XLogP3
2.1
Consensus LogP
2.44
Log S (ESOL)
-3.45
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.05
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.14
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.84
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5
